LLYON
li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Name LLYON
Rank No.1188
Market Cap $5.63M
Fully Diluted Market Cap $5.63M
Market Share %
Trading Vol/Market Cap (24H) 38,569.35%
Circulation Supply 4.38K
Max Supply 0
Total Supply 4,381.47646015
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 1323.5615671931544, 2026-10-22
Lowest Price 712.8133541417105, 2025-09-25
Public Blockchain LLYON
Introduction li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Sector
- common.mc-trade-zone-xStocks
Social Media
Fund Flow Analysis
|
Buy(LLYON) |
Sell(LLYON) |
Net Inflow |
| Big |
0.000 |
1.562K |
-1562.346 |
| Medium |
964.867 |
347.020 |
617.847 |
| Small |
58.842 |
789.094 |
-730.251 |
| Total |
1.024K |
2.698K |
-1674.750 |
Disclaimer: Data provided by cmc and should not be considered as investment advice.